Home/Filings/4/0001144204-13-039585
4//SEC Filing

ProPhase Labs, Inc. 4

Accession 0001144204-13-039585

$PRPHCIK 0000868278operating

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 5:01 PM ET

Size

5.9 KB

Accession

0001144204-13-039585

Insider Transaction Report

Form 4
Period: 2013-07-15
Transactions
  • Award

    Common Stock, par value $0.0005

    2013-07-15+5,490275,685 total
Holdings
  • Common Stock, par value $0.0005

    (indirect: By Foundation)
    180,000
Footnotes (2)
  • [F1]These restricted shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors.
  • [F2]The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Issuer

ProPhase Labs, Inc.

CIK 0000868278

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000868278

Filing Metadata

Form type
4
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 5:01 PM ET
Size
5.9 KB